99 related articles for article (PubMed ID: 12043839)
1. EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.
Shir A; Ogris M; Wagner E; Levitzki A
PLoS Med; 2006 Jan; 3(1):e6. PubMed ID: 16318410
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
Shir A; Levitzki A
Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839
[No Abstract] [Full Text] [Related]
3. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
Kane JR; Miska J; Young JS; Kanojia D; Kim JW; Lesniak MS
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii24-ii36. PubMed ID: 25746089
[TBL] [Abstract][Full Text] [Related]
4. Viral vector: potential therapeutic for glioblastoma multiforme.
Manikandan C; Kaushik A; Sen D
Cancer Gene Ther; 2020 May; 27(5):270-279. PubMed ID: 31316136
[TBL] [Abstract][Full Text] [Related]
5. [Tumor-targeting gene therapy: Ras-dependent oncolytic viral vectors].
Hamada H
Uirusu; 2003 Dec; 53(2):195-9. PubMed ID: 15071958
[No Abstract] [Full Text] [Related]
6. Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
Kim HA; Lee HL; Choi E; Kim YH; Lee M
J Pharm Sci; 2015 Nov; 104(11):3743-3751. PubMed ID: 26178805
[TBL] [Abstract][Full Text] [Related]
7. Viral therapy for glioblastoma.
Chiocca EA; Aghi M; Fulci G
Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR.
Shir A; Levitzki A
Nat Biotechnol; 2002 Sep; 20(9):895-900. PubMed ID: 12205508
[TBL] [Abstract][Full Text] [Related]
9. Reovirus as an oncolytic agent against experimental human malignant gliomas.
Wilcox ME; Yang W; Senger D; Rewcastle NB; Morris DG; Brasher PM; Shi ZQ; Johnston RN; Nishikawa S; Lee PW; Forsyth PA
J Natl Cancer Inst; 2001 Jun; 93(12):903-12. PubMed ID: 11416111
[TBL] [Abstract][Full Text] [Related]
10. Malignant glioma: genetics and biology of a grave matter.
Maher EA; Furnari FB; Bachoo RM; Rowitch DH; Louis DN; Cavenee WK; DePinho RA
Genes Dev; 2001 Jun; 15(11):1311-33. PubMed ID: 11390353
[No Abstract] [Full Text] [Related]
11. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor in human glioma cells.
Zheng SX; Zhou LJ; Zhu XZ; Jin YX
Acta Pharmacol Sin; 2000 Mar; 21(3):211-4. PubMed ID: 11324417
[TBL] [Abstract][Full Text] [Related]
12. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
Hughes C; Galea-Lauri J; Farzaneh F; Darling D
Mol Ther; 2001 Apr; 3(4):623-30. PubMed ID: 11319925
[TBL] [Abstract][Full Text] [Related]
13. PTEN controls tumor-induced angiogenesis.
Wen S; Stolarov J; Myers MP; Su JD; Wigler MH; Tonks NK; Durden DL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4622-7. PubMed ID: 11274365
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
